MedTrace Logo

MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners

NCT04093739 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-12-13

No results posted yet for this study

Summary

The objective of this consecutive series PMCF study is to collect data confirming safety, performance and clinical benefits of the G7 Freedom Constrained Liners when used for primary and revision total hip arthroplasty (implants and instrumentation) at 5 years follow-up. Since G7 Acetabular Cup System has only been on the market since 2015, a prospective follow-up will be necessary to obtain data for the 5 year post-surgery time-point for each patient.

Conditions

  • Hip Osteoarthritis
  • Hip Disease
  • Hip Fractures
  • Hip Injuries

Interventions

DEVICE

G7 Freedom Constrained Liners

Patients that have been implanted with the G7 Freedom Constrained Liners to repair hip malfunction and/or disease.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Erin Osborn · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-30
Primary Completion
2029-12-31
Completion
2029-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04093739 on ClinicalTrials.gov